Incorporation of a micronucleus study into a developmental toxicology and pharmacokinetic study of L-selenomethionine in nonhuman primates

W. N. Choy, P. R. Henika, C. C. Willhite, Alice F Tarantal

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Concomitant to a developmental toxicology study of selenium in long-tailed macaques (Macaca fascicularis), a transplacental bone marrow micronucleus assay was conducted in the fetuses of treated animals. Selenium was administered as L-selenomethionine by nasogastric intubation at 0, 150 or 300 μg/kg-day to pregnant macaques daily throughout organo-genesis (gestation days 20-50). Pregnancy was terminated on gestation day 100 ± 2 and fetuses were obtained by hystereotomy. Selenium concentrations in maternal blood were monitored throughout pregnancy and selenium concentrations in fetal blood were measured at hysterotomy. Matenal circulating selenium did not exceed 4 ppm in plasma or 3.7 ppm in erythrocytes. Selenium in cord blood was ≤0.1 ppm in plasma and ≤1.1 ppm in erythrocytes at 300 μg/kg-day. Fetal bone marrow smears were prepared from the humerus and micronucleated polychromatic erythrocytes were scored. No increase of micronucleus frequency was detected in any dose group, although signs of maternal selenosis were obvious. This finding is compared to the previous observation that micronuclei were induced in the bone marrow of adult nonpregnant macaques treated at 600 μg/kg-day, a lethal dose yielding blood selenium levels to 7.3 ppm in plasma and 5.7 ppm in erythrocytes after 15 days of daily treatment, when death occurred. These data demonstrate that measurement of circulating xenobiotics can be useful for the interpretation of genetic toxicology results.

Original languageEnglish (US)
Pages (from-to)73-80
Number of pages8
JournalEnvironmental and Molecular Mutagenesis
Volume21
Issue number1
DOIs
StatePublished - 1993

Fingerprint

Selenomethionine
Pharmacokinetics
toxicology
Selenium
selenium
primate
Toxicology
Primates
pregnancy
Macaca
Blood
Erythrocytes
blood
bone
Pregnancy
Bone
Bone Marrow
Fetal Blood
Plasmas
plasma

Keywords

  • Cynomolgus monkey
  • L-selenomethionine
  • Micronucleus test
  • Pharmacokinetics
  • Risk assessment
  • Selenium

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Genetics
  • Genetics(clinical)
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Incorporation of a micronucleus study into a developmental toxicology and pharmacokinetic study of L-selenomethionine in nonhuman primates. / Choy, W. N.; Henika, P. R.; Willhite, C. C.; Tarantal, Alice F.

In: Environmental and Molecular Mutagenesis, Vol. 21, No. 1, 1993, p. 73-80.

Research output: Contribution to journalArticle

@article{359046cf30414aaea9f716ee321105c0,
title = "Incorporation of a micronucleus study into a developmental toxicology and pharmacokinetic study of L-selenomethionine in nonhuman primates",
abstract = "Concomitant to a developmental toxicology study of selenium in long-tailed macaques (Macaca fascicularis), a transplacental bone marrow micronucleus assay was conducted in the fetuses of treated animals. Selenium was administered as L-selenomethionine by nasogastric intubation at 0, 150 or 300 μg/kg-day to pregnant macaques daily throughout organo-genesis (gestation days 20-50). Pregnancy was terminated on gestation day 100 ± 2 and fetuses were obtained by hystereotomy. Selenium concentrations in maternal blood were monitored throughout pregnancy and selenium concentrations in fetal blood were measured at hysterotomy. Matenal circulating selenium did not exceed 4 ppm in plasma or 3.7 ppm in erythrocytes. Selenium in cord blood was ≤0.1 ppm in plasma and ≤1.1 ppm in erythrocytes at 300 μg/kg-day. Fetal bone marrow smears were prepared from the humerus and micronucleated polychromatic erythrocytes were scored. No increase of micronucleus frequency was detected in any dose group, although signs of maternal selenosis were obvious. This finding is compared to the previous observation that micronuclei were induced in the bone marrow of adult nonpregnant macaques treated at 600 μg/kg-day, a lethal dose yielding blood selenium levels to 7.3 ppm in plasma and 5.7 ppm in erythrocytes after 15 days of daily treatment, when death occurred. These data demonstrate that measurement of circulating xenobiotics can be useful for the interpretation of genetic toxicology results.",
keywords = "Cynomolgus monkey, L-selenomethionine, Micronucleus test, Pharmacokinetics, Risk assessment, Selenium",
author = "Choy, {W. N.} and Henika, {P. R.} and Willhite, {C. C.} and Tarantal, {Alice F}",
year = "1993",
doi = "10.1002/em.2850210110",
language = "English (US)",
volume = "21",
pages = "73--80",
journal = "Environmental and Molecular Mutagenesis",
issn = "0893-6692",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Incorporation of a micronucleus study into a developmental toxicology and pharmacokinetic study of L-selenomethionine in nonhuman primates

AU - Choy, W. N.

AU - Henika, P. R.

AU - Willhite, C. C.

AU - Tarantal, Alice F

PY - 1993

Y1 - 1993

N2 - Concomitant to a developmental toxicology study of selenium in long-tailed macaques (Macaca fascicularis), a transplacental bone marrow micronucleus assay was conducted in the fetuses of treated animals. Selenium was administered as L-selenomethionine by nasogastric intubation at 0, 150 or 300 μg/kg-day to pregnant macaques daily throughout organo-genesis (gestation days 20-50). Pregnancy was terminated on gestation day 100 ± 2 and fetuses were obtained by hystereotomy. Selenium concentrations in maternal blood were monitored throughout pregnancy and selenium concentrations in fetal blood were measured at hysterotomy. Matenal circulating selenium did not exceed 4 ppm in plasma or 3.7 ppm in erythrocytes. Selenium in cord blood was ≤0.1 ppm in plasma and ≤1.1 ppm in erythrocytes at 300 μg/kg-day. Fetal bone marrow smears were prepared from the humerus and micronucleated polychromatic erythrocytes were scored. No increase of micronucleus frequency was detected in any dose group, although signs of maternal selenosis were obvious. This finding is compared to the previous observation that micronuclei were induced in the bone marrow of adult nonpregnant macaques treated at 600 μg/kg-day, a lethal dose yielding blood selenium levels to 7.3 ppm in plasma and 5.7 ppm in erythrocytes after 15 days of daily treatment, when death occurred. These data demonstrate that measurement of circulating xenobiotics can be useful for the interpretation of genetic toxicology results.

AB - Concomitant to a developmental toxicology study of selenium in long-tailed macaques (Macaca fascicularis), a transplacental bone marrow micronucleus assay was conducted in the fetuses of treated animals. Selenium was administered as L-selenomethionine by nasogastric intubation at 0, 150 or 300 μg/kg-day to pregnant macaques daily throughout organo-genesis (gestation days 20-50). Pregnancy was terminated on gestation day 100 ± 2 and fetuses were obtained by hystereotomy. Selenium concentrations in maternal blood were monitored throughout pregnancy and selenium concentrations in fetal blood were measured at hysterotomy. Matenal circulating selenium did not exceed 4 ppm in plasma or 3.7 ppm in erythrocytes. Selenium in cord blood was ≤0.1 ppm in plasma and ≤1.1 ppm in erythrocytes at 300 μg/kg-day. Fetal bone marrow smears were prepared from the humerus and micronucleated polychromatic erythrocytes were scored. No increase of micronucleus frequency was detected in any dose group, although signs of maternal selenosis were obvious. This finding is compared to the previous observation that micronuclei were induced in the bone marrow of adult nonpregnant macaques treated at 600 μg/kg-day, a lethal dose yielding blood selenium levels to 7.3 ppm in plasma and 5.7 ppm in erythrocytes after 15 days of daily treatment, when death occurred. These data demonstrate that measurement of circulating xenobiotics can be useful for the interpretation of genetic toxicology results.

KW - Cynomolgus monkey

KW - L-selenomethionine

KW - Micronucleus test

KW - Pharmacokinetics

KW - Risk assessment

KW - Selenium

UR - http://www.scopus.com/inward/record.url?scp=0027511546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027511546&partnerID=8YFLogxK

U2 - 10.1002/em.2850210110

DO - 10.1002/em.2850210110

M3 - Article

C2 - 8419156

AN - SCOPUS:0027511546

VL - 21

SP - 73

EP - 80

JO - Environmental and Molecular Mutagenesis

JF - Environmental and Molecular Mutagenesis

SN - 0893-6692

IS - 1

ER -